Aurobindo Pharma has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Cephalexin Tablets USP, 250 mg and 500 mg, which is bioequivalent and ...

Hyderabad: Aurobindo Pharma Limited has announced that it has received final approval from the US Food & Drug Administration ...

Aurobindo Pharma receives FDA approval for Cephalexin Tablets, bioequivalent to Keflet, with CGT designation and shared exclusivity.

Generic drugmaker Aurobindo Pharma has received final approval from the U.S. Food and Drug Administration to manufacture and market Cephalexin Tablets USP, 250 mg and 500 mg. Bioequivalent and ...

Aurobindo Pharma has also been granted competitive generic therapy designation for these Cephalexin Tablets, qualifying the ...

Aurobindo Pharma announced that it has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Cephalexin Tablets USP, 250 mg.

Hyderabad-headquartered Aurobindo Pharma has announced that it has received final approval from the U.S. Food and Drug Administration (USFDA) to manufacture and market Cephalexin Tablets USP in both ...

An outside physician prescribed cephalexin 500 mg b.i.d. The patient denied fever, chills, night sweats, or recent work in the soil. He lived on a farm with daily exposure to cattle, cats ...

However, if the lesions are more severe or persistent, adults may be prescribed cephalexin 500 mg by mouth twice daily for 10 days, ofloxacin 400 mg by mouth twice daily for 10 days, dicloxacillin ...

Zydus Lifesciences, Maruti Suzuki India, Dabur India, South Indian Bank, Allcargo Logistics, International Conveyors, NMDC, ...

GIFT Nifty ended 229 points or 0.88% down at 25,801 indicating a negative opening for domestic indices NSE Nifty 50 and BSE ...

Vistra Corp. $138.41 5.96 4.50% ...